2024 HCPCS Code G9094
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
TAGS: adenocarcinoma invasive disease demonstration limited rectal locally predominant progressive
| Short Description | Onc dx rectal m1 w/mets prog |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G9116 - Onc dx ovarian recurrence
- G9117 - Onc dx ovarian unknown nos
- G9123 - Onc dx cml chronic phase
- G9124 - Onc dx cml acceler phase
- G9125 - Onc dx cml blast phase
- G9126 - Onc dx cml remission
- G9128 - Onc dx multi myeloma stage i
- G9129 - Onc dx mult myeloma stg2 hig
- G9130 - Onc dx multi myeloma unknown
- G9131 - Onc dx brst unknown nos
- G9132 - Onc dx prostate mets no cast
- G9133 - Onc dx prostate clinical met
- G9134 - Onc nhlstg 1-2 no relap no
- G9135 - Onc dx nhl stg 3-4 not relap
- G9136 - Onc dx nhl trans to lg bcell
- G9137 - Onc dx nhl relapse/refractor
- G9138 - Onc dx nhl stg unknown
- G9139 - Onc dx cml dx status unknown
- G9140 - Frontier extended stay demo
- G9143 - Warfarin respon genetic test